V Square Quantitative Management LLC Purchases 53 Shares of McKesson Co. (NYSE:MCK)

V Square Quantitative Management LLC raised its position in McKesson Co. (NYSE:MCK) by 4.7% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 1,182 shares of the company’s stock after buying an additional 53 shares during the period. V Square Quantitative Management LLC’s holdings in McKesson were worth $674,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of MCK. Creative Planning boosted its position in shares of McKesson by 2.1% in the 3rd quarter. Creative Planning now owns 63,328 shares of the company’s stock worth $31,064,000 after purchasing an additional 1,316 shares during the last quarter. Wolff Wiese Magana LLC boosted its position in shares of McKesson by 742.9% in the 3rd quarter. Wolff Wiese Magana LLC now owns 59 shares of the company’s stock worth $29,000 after purchasing an additional 52 shares during the last quarter. Good Life Advisors LLC boosted its position in shares of McKesson by 36.9% in the 3rd quarter. Good Life Advisors LLC now owns 1,064 shares of the company’s stock worth $526,000 after purchasing an additional 287 shares during the last quarter. Trust Co. of Vermont boosted its position in shares of McKesson by 7.8% in the 3rd quarter. Trust Co. of Vermont now owns 375 shares of the company’s stock worth $185,000 after purchasing an additional 27 shares during the last quarter. Finally, TruWealth Advisors LLC boosted its position in shares of McKesson by 8.3% in the 3rd quarter. TruWealth Advisors LLC now owns 983 shares of the company’s stock worth $486,000 after purchasing an additional 75 shares during the last quarter. 85.07% of the stock is currently owned by institutional investors.

McKesson Stock Down 1.4 %

Shares of NYSE:MCK opened at $593.82 on Friday. The stock has a market cap of $75.38 billion, a PE ratio of 27.19, a P/E/G ratio of 1.30 and a beta of 0.52. The business has a 50 day moving average of $587.46 and a 200-day moving average of $563.18. McKesson Co. has a 12-month low of $464.42 and a 12-month high of $637.51.

McKesson (NYSE:MCK) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $8.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $8.60 by ($0.57). McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. Equities research analysts expect that McKesson Co. will post 32.69 earnings per share for the current year.

McKesson Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 1st. Shareholders of record on Monday, March 3rd will be given a dividend of $0.71 per share. The ex-dividend date of this dividend is Monday, March 3rd. This represents a $2.84 dividend on an annualized basis and a yield of 0.48%. McKesson’s dividend payout ratio (DPR) is currently 13.00%.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on MCK shares. Mizuho started coverage on McKesson in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $630.00 price target on the stock. Bank of America dropped their price objective on McKesson from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Morgan Stanley raised their price objective on McKesson from $612.00 to $642.00 and gave the stock an “overweight” rating in a research note on Tuesday, December 17th. Baird R W raised McKesson from a “hold” rating to a “strong-buy” rating in a research note on Thursday, November 7th. Finally, Citigroup dropped their price objective on McKesson from $713.00 to $677.00 and set a “buy” rating on the stock in a research note on Friday, January 10th. Two research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, McKesson presently has an average rating of “Moderate Buy” and a consensus price target of $645.79.

Insider Buying and Selling at McKesson

In other news, EVP Leann B. Smith sold 579 shares of the stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $572.79, for a total transaction of $331,645.41. Following the transaction, the executive vice president now owns 864 shares of the company’s stock, valued at $494,890.56. This represents a 40.12 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Over the last quarter, insiders have sold 1,346 shares of company stock valued at $795,275. 0.11% of the stock is currently owned by insiders.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.